Literature DB >> 2529852

Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.

M F Scully1, V Ellis, N Shah, V Kakkar.   

Abstract

The kinetics of inhibition of human alpha-thrombin and coagulation Factor Xa by antithrombin III were examined under pseudo-first-order reaction conditions as a function of the concentration of heparan sulphate with high affinity for antithrombin III. The maximum observed second-order rate constant was, for the antithrombin III-thrombin reaction, 1.2 x 10(9) M-1.min-1 compared with 2.4 x 10(9) M-1.min-1 in the presence of high-affinity heparin. However, the maximum rate was catalysed by much higher concentrations of heparan sulphate (1.3 microM) than of heparin (0.025 microM). Differences were also observed in the maximal acceleration of the antithrombin III-Factor Xa interaction: 1.2 x 10(9) M-1.min-1 at 0.2 microM-heparin sulphate compared with 2.2 x 10(9) M-1.min-1 at 0.04 microM-heparin. The differences in properties of heparan sulphate and heparin were analysed by using the random bi-reactant model of heparin action [Griffith (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 5460-5464]. It was observed that the apparent binding affinity for thrombin was higher for heparan sulphate (180 nM) than for heparin (14 nM). The rate constant for transformation of the antithrombin III-Factor Xa complex into irreversible product differed between heparan sulphate (96 min-1) and heparin (429 min-1). These properties of the high-affinity heparan sulphate may be of importance in consideration of a putative role in the control of intravascular haemostasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529852      PMCID: PMC1133317          DOI: 10.1042/bj2620651

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  58 in total

1.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

2.  Anticoagulant action of heparin.

Authors:  P S Damus; M Hicks; R D Rosenberg
Journal:  Nature       Date:  1973-12-07       Impact factor: 49.962

3.  The interaction of thrombin and heparin. Proflavine dye binding studies.

Authors:  E H Li; C Orton; R D Feinman
Journal:  Biochemistry       Date:  1974-11-19       Impact factor: 3.162

4.  Electrophoresis of acidic glycosaminoglycans in hydrochloric acid: a micro method for sulfate determination.

Authors:  E Wessler
Journal:  Anal Biochem       Date:  1971-05       Impact factor: 3.365

5.  Anticoagulantly active heparin-like molecules from vascular tissue.

Authors:  J A Marcum; R D Rosenberg
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

Review 6.  Antithrombin III deficiency and thromboembolism.

Authors:  E Thaler; K Lechner
Journal:  Clin Haematol       Date:  1981-06

7.  Fractionation of heparin using antithrombin III reversibly bound to concanavalin A-sepharose.

Authors:  J Denton; W E Lewis; I A Nieduszynski; C F Phelps
Journal:  Anal Biochem       Date:  1981-12       Impact factor: 3.365

8.  Circular dichroism spectroscopy of heparin-antithrombin interactions.

Authors:  A L Stone; D Beeler; G Oosta; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Heparan sulphate with no affinity for antithrombin III and the control of haemostasis.

Authors:  M F Scully; V Ellis; V V Kakkar
Journal:  FEBS Lett       Date:  1988-12-05       Impact factor: 4.124

10.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

Authors:  J A Marcum; D H Atha; L M Fritze; P Nawroth; D Stern; R D Rosenberg
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.